当前位置:首页 > 报告详情

1550_Jaffer.pdf

上传人: 明**** 编号:1012282 2025-12-21 20页 1,016.11KB

1、Lytics and Thrombectomy Devices:How and When do I Choose and Use?Osman Jaffer,MD.Staff Coronary and Peripheral Interventional Cardiologist:Hartford Health CareCatheter Directed Thrombolysis(CDT)vs.Devices:How Do We Choose?Heterogenous population set Vast array of tools to use Extremely important to

2、involve vascular surgeons Prior to 1950,amputation was mainstay of treatment Fogarty arterial embolectomy catheter developed in 1961 by Dr.Thomas Fogarty Surgical bypassCatheter Directed Thrombolysis(CDT)vs.Devices:How Do We Choose?J Vasc Surg.2013 October;58(4):949956.doi:10.1016/j.jvs.2013.04.036.

3、323 bypass for ALI-5000 for CLIHigher morbidity for-ALI patients(20%vs.12%)Higher limb loss at 1 year(22%vs.10%)Highter mortality at 1 year(21%vs.12%)Catheter Directed Thrombolysis(CDT)vs.Devices:How Do We Choose?Percutaneous options CDT Thrombectomy Devices HybridCatheter Directed Thrombolysis(CDT)

4、vs.Devices:How Do We Choose?Advantages to CDT:Percutaneous TherapyLess invasive Decreases morbidity of surgery Decreases reperfusion injury Identifies lesions that need to be treated Applicable to subacute lesionsAny proven clinical benefit?Catheter Directed Thrombolysis(CDT)vs.Devices:How Do We Cho

5、ose?Endovascular Treatment for ALI:CDTCatheter Directed Thrombolysis(CDT)vs.Devices:How Do We Choose?Endovascular Treatment for ALI:CDTCatheter Directed Thrombolysis(CDT)vs.Devices:How Do We Choose?Endovascular Treatment for ALI:CDTTrial stopped early at only 393 patient recruitment because of hitti

6、ng hard clinical endpoint of safetyMet endpoint in the CDT group vs surgery,primarily driven by ongoing/recurrent ischemiaCatheter Directed Thrombolysis(CDT)vs.Devices:How Do We Choose?Endovascular Treatment for ALI:CDTHowever,in subset data those patients with 150 Angiojet secon

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
根据文章内容,以下是全文关键点的概括: 1. **治疗选择**:在动脉缺血性肢体(ALI)的治疗中,选择Catheter Directed Thrombolysis (CDT)或Percutaneous Mechanical Thrombectomy (PMT)。 2. **CDT优势**:CDT是一种侵入性较小的治疗,可减少手术的并发症和再灌注损伤,适用于亚急性病变。 3. **CDT局限性**:CDT需要2-4天的输液时间,需要ICU级别的护理,并存在出血和对比剂及辐射暴露的风险。 4. **PMT应用**:PMT在ALI治疗中作为一线治疗,可快速再灌注肢体,减少手术时间,风险可接受。 5. **临床研究**:一项研究显示,PMT在无腘下侵犯的患者中,以及那些无需CDT的PMT患者中,显示出更好的结果。 6. **结论**:CDT在缺血时间少于14天的患者中优于手术再血管化;PMT可减少溶栓暴露的出血风险并缩短再灌注时间;在决策时需考虑外科团队的意见。
"血栓清除器选谁?" "CDT与机械血栓切除术,怎么选?" "下肢缺血,哪种治疗最有效?"
客服
商务合作
小程序
服务号
折叠